ZURICH & PHILADELPHIA & COPENHAGEN, Denmark, January 15, 2026--(BUSINESS WIRE)--InterAx Biotech Ltd ("InterAx") and Alveus Therapeutics Inc. ("Alveus") today announced a strategic research ...
InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results